Lee Ainslie’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.9M Buy
978,617
+264,536
+37% +$17.5M 0.6% 42
2026
Q1
$49.2M Buy
714,081
+227,915
+47% +$17.8M 0.57% 44
2025
Q4
$42.9M Sell
486,166
-1,124,048
-70% -$95.7M 0.46% 43
2025
Q3
$134M Buy
1,610,214
+230,806
+17% +$20.1M 1.79% 19
2025
Q2
$129M Buy
1,379,408
+106,897
+8% +$10.1M 1.94% 18
2025
Q1
$135M Buy
+1,272,511
New +$131M 2.38% 12
2023
Q1
Sell
-5,612
Closed -$396K 514
2022
Q4
$396K Buy
5,612
+511
+10% +$34.1K 0.01% 221
2022
Q3
$288K Buy
+5,101
New +$294K 0.01% 236
2022
Q1
Sell
-2,004
Closed -$125K 317
2021
Q4
$125K Sell
2,004
-13,871
-87% -$929K ﹤0.01% 155
2021
Q3
$1.14M Sell
15,875
-13,493
-46% -$915K 0.01% 270
2021
Q2
$1.9M Buy
29,368
+474
+2% +$29.3K 0.02% 174
2021
Q1
$1.73M Buy
28,894
+7,644
+36% +$438K 0.02% 169
2020
Q4
$1.18M Buy
+21,250
New +$1.1M 0.02% 210

Other funds holding MMSI

Lee Ainslie's MMSI Position: Q2 2026 in Review

Lee Ainslie increased its Merit Medical Systems (MMSI) stake by 37% in Q2 2026, buying an estimated $17.5M and bringing the position to 978,617 shares worth $67.9M. The position accounts for 0.6% of the portfolio, ranked #42.

Lee Ainslie first reported a position in MMSI in Q4 2020 and has held it in 13 quarters since. The position peaked at $135M in Q1 2025. 402 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Lee Ainslie held 978,617 shares of Merit Medical Systems worth $67.9M as of Q2 2026.
  • Lee Ainslie bought 264,536 Merit Medical Systems shares in Q2 2026, an estimated $17.5M.
  • Merit Medical Systems made up 0.6% of Lee Ainslie's portfolio in Q2 2026, its #42 holding.
  • Lee Ainslie first reported a position in Merit Medical Systems in Q4 2020 and has held it in 13 quarters since.
  • Lee Ainslie's Merit Medical Systems position peaked at $135M in Q1 2025.
  • 402 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.